Skip to content

Clinical trials

Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Clear all

651 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
200115
200213
200316
200417
200522
200620
200726
200833
200922
201026
201133
201217
201327
201424
201517
201626
201721
201820
201916
202017
202123
202215
202318
202426
202522
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed332
Recruiting90
Terminated64
Active, not recruiting56
Unknown status55
Withdrawn26
Not yet recruiting10
No longer available6
Available6
Enrolling by invitation4
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)68
Children's Oncology Group57
Memorial Sloan Kettering Cancer Center50
New Approaches to Neuroblastoma Therapy Consortium24
St. Jude Children's Research Hospital23
Giselle Sholler18
Baylor College of Medicine14
Fred Hutchinson Cancer Center14
Children's Cancer and Leukaemia Group13
Dana-Farber Cancer Institute10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma651
Sarcoma120
Osteosarcoma116
Wilms Tumor112
Rhabdomyosarcoma91
Medulloblastoma84
Neoplasms84
Sarcoma, Ewing79
Recurrence75
Lymphoma, Non-Hodgkin71

Trials

Showing 51 to 75 of 651. Each trial links to its page on Pharma Observatory.

551 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.